FDA Inspection
Oklahoma Blood Institute East CentralOklahoma Blood Institute East Central – FDA Inspection, Mar 6, 2014
Record Details
This FDA Inspection record concerns Oklahoma Blood Institute East Central, with an inspection on March 6, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 6, 2014
- Product Type
- Biologics
View Company Profile
ID · ad35e1a2-a0ba-4d3c-9c66-f96870143053
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 868819
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.60(b)Equipment calibration frequency
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Oklahoma Blood Institute East Central
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 7, 2026 | Not classified | Dallas District Office | |
| December 11, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 3, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 16, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 7, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Oklahoma Blood Institute East Central
- FDA Inspection 1318372 - 2026-05-07
- FDA Inspection 1113288 - 2019-12-11
- FDA Inspection 1063022 - 2018-08-03
- FDA Inspection 970700 - 2016-03-16
- FDA Inspection 772469 - 2012-03-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.